Ana Lucrecia Woodward

Array ( [id] => 5398405 [patent_doc_number] => 20090318468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'PYRAZOLE COMPOUNDS 436' [patent_app_type] => utility [patent_app_number] => 12/487838 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14766 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318468.pdf [firstpage_image] =>[orig_patent_app_number] => 12487838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570333 [patent_doc_number] => 20090253711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'HETEROCYCLYL-3-SULFONYLINDAZOLES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS' [patent_app_type] => utility [patent_app_number] => 12/483344 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11258 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253711.pdf [firstpage_image] =>[orig_patent_app_number] => 12483344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497852 [patent_doc_number] => 20100094005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'FLUORINATED DERIVATIVE OF QUINOLIN-2(1H)-ONE, METHOD FOR PREPARING THE SAME AND USE THEREOF AS A SYNTHESIS INTERMEDIATE' [patent_app_type] => utility [patent_app_number] => 12/483288 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2270 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20100094005.pdf [firstpage_image] =>[orig_patent_app_number] => 12483288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374766 [patent_doc_number] => 20090312327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'PYRROLIDINE DERIVATIVES AS NK2 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/482490 [patent_app_country] => US [patent_app_date] => 2009-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31913 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312327.pdf [firstpage_image] =>[orig_patent_app_number] => 12482490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474375 [patent_doc_number] => 20090247541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Novel compounds' [patent_app_type] => utility [patent_app_number] => 12/480182 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8192 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247541.pdf [firstpage_image] =>[orig_patent_app_number] => 12480182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944854 [patent_doc_number] => 20110105474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'HETEROCYCLIC DERIVATIVES AS HDAC INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/997191 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27746 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105474.pdf [firstpage_image] =>[orig_patent_app_number] => 12997191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637087 [patent_doc_number] => 20100035879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS' [patent_app_type] => utility [patent_app_number] => 12/474610 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19217 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035879.pdf [firstpage_image] =>[orig_patent_app_number] => 12474610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465764 [patent_doc_number] => 20090325964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression' [patent_app_type] => utility [patent_app_number] => 12/470814 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34032 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325964.pdf [firstpage_image] =>[orig_patent_app_number] => 12470814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987181 [patent_doc_number] => 20110098305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'ARYLSULFONAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/993574 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65313 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098305.pdf [firstpage_image] =>[orig_patent_app_number] => 12993574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4372 [patent_doc_number] => 07816362 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-19 [patent_title] => 'Serotonergic agents' [patent_app_type] => utility [patent_app_number] => 12/435862 [patent_app_country] => US [patent_app_date] => 2009-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3117 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/816/07816362.pdf [firstpage_image] =>[orig_patent_app_number] => 12435862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53380 [patent_doc_number] => 07772252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands' [patent_app_type] => utility [patent_app_number] => 12/425731 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44292 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772252.pdf [firstpage_image] =>[orig_patent_app_number] => 12425731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4570516 [patent_doc_number] => 07858627 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Topoisomerase-targeting agents' [patent_app_type] => utility [patent_app_number] => 12/422394 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11776 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858627.pdf [firstpage_image] =>[orig_patent_app_number] => 12422394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7540420 [patent_doc_number] => 08058263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Substituted 2-phenyl-pyridine derivatives' [patent_app_type] => utility [patent_app_number] => 12/936661 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25444 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058263.pdf [firstpage_image] =>[orig_patent_app_number] => 12936661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5569401 [patent_doc_number] => 20090252779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'AZAINDAZOLE COMPOUNDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/418516 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42130 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20090252779.pdf [firstpage_image] =>[orig_patent_app_number] => 12418516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196686 [patent_doc_number] => 20110028444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'PHARMACEUTICALLY ACCEPTABLE SALTS OF ANTI-INFECTION QUINOLONE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/936088 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7696 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028444.pdf [firstpage_image] =>[orig_patent_app_number] => 12936088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501756 [patent_doc_number] => 20110263610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/935273 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38094 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263610.pdf [firstpage_image] =>[orig_patent_app_number] => 12935273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404534 [patent_doc_number] => 20090239848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE' [patent_app_type] => utility [patent_app_number] => 12/408367 [patent_app_country] => US [patent_app_date] => 2009-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29509 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239848.pdf [firstpage_image] =>[orig_patent_app_number] => 12408367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436264 [patent_doc_number] => 20090170851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Chroman Compounds' [patent_app_type] => utility [patent_app_number] => 12/403553 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26282 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170851.pdf [firstpage_image] =>[orig_patent_app_number] => 12403553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097219 [patent_doc_number] => 20110003691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Substituted Pyrazinylmethyl Sulfonamides For Use As Fungicides' [patent_app_type] => utility [patent_app_number] => 12/921504 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27838 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003691.pdf [firstpage_image] =>[orig_patent_app_number] => 12921504 [rel_patent_id] =>[rel_patent_doc_number] =>)